Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome (Q36238260)

13 August 2017

Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome (English)

1 reference

immune reconstitution inflammatory syndrome

13 August 2017

0 references

0 references

1 reference

11

1 reference

13 August 2017

Rebecca Tadokera

5

0 references

Graeme Meintjes

Graeme Meintjes

1

0 references

Gary Maartens

Gary Maartens

13

0 references

Robert J. Wilkinson

Robert J Wilkinson

14

0 references

Robert Colebunders

12

Robert Colebunders

1 reference

13 August 2017

3

Katalin A Wilkinson

1 reference

13 August 2017

Keira H Skolimowska

2

1 reference

13 August 2017

Kerryn Matthews

4

1 reference

13 August 2017

Anali Conesa-Botella

6

1 reference

13 August 2017

Ronnett Seldon

7

1 reference

13 August 2017

Molebogeng X Rangaka

8

1 reference

13 August 2017

Kevin Rebe

9

1 reference

13 August 2017

Dominique J Pepper

10

1 reference

13 August 2017

language of work or name

English

0 references

publication date

14 June 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

13 August 2017

1 reference

13 August 2017

186

1 reference

13 August 2017

4

1 reference

13 August 2017

369-377

1 reference

Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Leprosy type 1 (reversal) reactions and their management.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Advances in the treatment of reactions in leprosy.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

C-reactive protein: a critical update

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Molecular mechanisms of corticosteroid actions

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443811

Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up

29 June 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201201-0094OC

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201201-0094OC

Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201201-0094OC

Ex Vivo Characterization of Early Secretory Antigenic Target 6-Specific T Cells at Sites of Active Disease in Pleural Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201201-0094OC

Mediators of Innate and Adaptive Immune Responses Differentially Affect Immune Restoration Disease Associated withMycobacterium tuberculosisin HIV Patients Beginning Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201201-0094OC

Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201201-0094OC

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22700860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22700860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22700860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1164/RCCM.201201-0094OC

1 reference

13 August 2017

1 reference

13 August 2017

1 reference